S
StageDotO
Venture CapitalActiveStageDotO is an early stage investment fund actively identifying pre-Series A companies driven by world-changing ideas.
23
Investments
1
Exits
$2M
AUM
4.3%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for StageDotO.
Investment Thesis & Strategy
StageDotO invests in pre-Series A fintech companies with innovative and impactful ideas. They are a venture capital firm focused on early-stage investments.
Investment Activity
Deals per year over the last 4 years
6
20183
20191
20202
2021Portfolio Companies
Selected investments from their portfolio of 23 companies
J
Jasper Therapeutics
Biotech · Series A, 2021
V
Vori Health
Healthcare · Series A, 2021
E
Everly Health
Healthcare · Series B, 2020
M
Modern Health
Healthcare · Series B, 2019
G
Ginger
Healthcare · Series C+, 2019
P
PathAI
Biotech · Series B, 2019
D
DispatchHealth
Healthcare · Series B, 2018
V
Viz.ai
Healthcare · Series A, 2018
C
Carbon Health
Healthcare · Series B, 2018
A
Alto Pharmacy
Healthcare · Series B, 2018
M
Maven Clinic
Healthcare · Series B, 2018
C
Cityblock Health
Healthcare · Series B, 2018
Frequently Asked Questions
StageDotO focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Madrona Venture Group
Seattle, United States · 359 deals
Vulcan Capital
Seattle, United States · 194 deals
Voyager Capital
Seattle, United States · 152 deals
OVP Venture Partners
Seattle, United States · 115 deals
Washington Research Foundation
Seattle, United States · 54 deals
Second Avenue Partners
Seattle, United States · 43 deals